|
|
||||||||
1 Medical, Surgical, and Research Services, Philadelphia Veterans Affairs Medical Center, and 2 Departments of Medicine, Surgery, and Cell and Developmental Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; and 3 Department of Exercise Science, University of Georgia, Athens, Georgia 30602
| |
ABSTRACT |
|---|
|
|
|---|
To assess the effect of severe chronic obstructive pulmonary disease (COPD) on the ability of human diaphragmatic myofibers to aerobically generate ATP relative to ATP utilization, we obtained biopsy specimens of the costal diaphragm from seven patients with severe COPD (mean ± SE; age 56 ± 1 yr; forced expiratory volume in 1 s 23 ± 2% predicted; residual volume 267 ± 30% predicted) and seven age-matched control subjects. We categorized all fibers in these biopsies by using standard techniques, and we carried out the following quantitative histochemical measurements by microdensitometry: 1) succinate dehydrogenase (SDH) activity as an indicator of mitochondrial oxidative capacity and 2) calcium-activated myosin ATPase (mATPase) activity, the ATPase that represents a major portion of ATP consumption by contracting muscle. We noted the following: 1) COPD diaphragms had a larger proportion of type I fibers, a lesser proportion of type IIax fibers, and the same proportion of type IIa fibers as controls. 2) SDH activities of each of the fiber types were higher in COPD than control diaphragms (P < 0.0001); the mean increases (expressed as percent of control values) in types I, IIa, and IIax were 84, 114, and 130%, respectively. 3) COPD elicited no change in mATPase activity of type I and IIa fibers, but mATPase decreased in type IIax fibers (P = 0.02). 4) Mitochondrial oxidative capacity relative to ATP demand (i.e., SDH/mATPase) was higher (P = 0.03) in each of the fiber types in COPD diaphragms than in controls. These results demonstrate that severe COPD elicits an increase in aerobic ATP generating capacity relative to ATP utilization in all diaphragmatic fiber types as well as the previously described fast-to-slow fiber type transformation (Levine S, Kaiser L, Leferovich J, and Tikunov B, N Engl J Med 337: 1799-1806, 1997).
chronic obstructive pulmonary disease; human diaphragm; succinate dehydrogenase; calcium-activated myosin ATPase; mitochondrial oxidative capacity; diaphragmatic fatigue; muscle fatigue
| |
INTRODUCTION |
|---|
|
|
|---|
OVER TWO DECADES AGO, Roussos and Macklem (44) demonstrated that the diaphragm, the major inspiratory muscle of humans, can become fatigued. In 1988, the National Institutes of Health Respiratory Muscle Fatigue Workshop (41) concluded that patients with chronic obstructive pulmonary disease (COPD) represented a clinical cohort likely to develop diaphragmatic fatigue. However, a major determinant of whether severe COPD patients will develop diaphragmatic fatigue is the bioenergetic adaptations elicited by severe COPD in the human diaphragm. To provide insight into the adaptations elicited by severe COPD in the human diaphragm, many investigators have studied diaphragmatic adaptations elicited by animal models of severe COPD.
In seminal experiments, Supinski and Kelsen and colleagues (23, 24, 26, 50) and Farkas and Roussos (12-14) studied the response of the hamster diaphragm to elastase-induced emphysema; 6-18 mo after the intratracheal instillation of elastase, they noted twofold increases in total lung capacity and a 20% decrease in diaphragmatic fiber length [measured in situ at a lung volume approximating functional residual capacity (FRC)]. Although the major focus of these studies was on the manner in which the diaphragm adapts to this in situ shortening, Farkas and Roussos noted that strips from these emphysematous hamster diaphragms exhibited an increased fatigue resistance (FR) (12) as well as an increase in citrate synthase activity (12, 14). Subsequently, Lewis et al. (34, 35) also demonstrated that strips from the emphysematous hamster diaphragm exhibited an increased FR, and they noted that elastase-induced emphysema also elicited increases in activity of succinate dehydrogenase (SDH), a marker enzyme of mitochondrial oxidative activity, in both type I and II fibers of the hamster diaphragm. Importantly, these latter authors pointed out that these increases in mitochondrial oxidative activity might be causally related to the increases in fatigue resistance.
Our laboratory previously hypothesized that severe COPD elicits adaptations in the human diaphragm that increase FR (32, 33). At the present time, because of technical difficulties, a satisfactory technique does not exist for in vitro assessment of FR of human diaphragmatic muscle strips. However, previous work by Van der Laarse et al. (51) as well as by Watchko and Sieck (52) showed that the ratio of oxidative ATP-generating capacity to ATP utilization, as evaluated by the ratio of SDH to the ATPase activity of the myosin heavy chain (MHC) (i.e., SDH/mATPase, where mATPase is the Ca2+-activated myosin ATPase), is the best biochemical reflector of FR at the cellular level. Therefore, our hypothesis predicts that severe COPD will elicit an increase in the SDH/mATPase. To test this hypothesis, we carried out quantitative measurements of fiber type-specific SDH activity and mATPase activities on intraoperative diaphragm biopsies obtained from seven subjects with severe COPD and seven control subjects.
| |
METHODS |
|---|
|
|
|---|
Subjects
Our COPD group consisted of three men and four women with severe COPD who were undergoing lung volume reduction surgery. In contrast, our control group was composed of two men and five women with mild pulmonary impairment [i.e., forced expiratory volume in 1 s (FEV1) between 70 and 100% predicted (1)] who were undergoing resection of solitary pulmonary nodules.Informed consent for diaphragm biopsies was obtained from each of the subjects, and our protocol was approved by the Institutional Review Boards of the Philadelphia Veterans Affairs Medical Center and the Hospital of the University of Pennsylvania.
Pulmonary Function Tests
Before surgery, all subjects underwent pulmonary function testing. Spirometry and plethysmographic lung volumes were measured by conventional techniques, and values were compared with predictions (22, 28).Biopsies
Full thickness biopsies (~15-25 mm by 6-8 mm) were obtained from the same region of the right anterior costal diaphragm lateral to the insertion of the phrenic nerve, frozen in isopentane within 3-5 min after excision [a time interval that yields fiber cross-sectional area (CSA) similar to CSA of fibers frozen with muscle fixed at the length producing maximum force (29, 30)], and then transferred into liquid nitrogen and stored at
70°C until
being used (32, 40).
General
We used standard qualitative histochemical myofibrillar ATPase activity (hATPase) for fiber typing (5, 19) and computation of CSA, whereas quantitative histochemical assays were used for measurements of the activities of SDH (3) and mATPase (4). All quantitative histochemical experiments were carried out in duplicate, and the results were averaged. Because a large number of sections were used for quantitative enzyme histochemistry, we stained two sections for hATPase: one section adjacent to those used for SDH and one section adjacent to those used for mATPase. Approximately 750 fibers from each diaphragm sample were analyzed for fiber types and SDH, a minimum of 50 fibers of each type was used for measurement of CSA, and a minimum of 30 fibers of each type was used for measurement of mATPase.Overview of methodology.
On removal from the freezer, specimens were placed in a cryostat
microtome (HM 505N, Microm) maintained at
20°C. Serial sections of
known thickness (6 or 10 µm) were then cut, placed onto coverslips, and air dried (30 min) before being assayed by either qualitative or
quantitative histochemical techniques. After these histochemical assays, images from the serial sections were digitized and subsequently analyzed for optical density (OD) and CSA, as previously described (7, 18, 27), by using public domain National Institutes of
Health Image analysis software. Our image analysis system consisted of
a Sony XC-77 charge-coupled device camera (Sony, Toyohashi, Japan)
attached to an Olympus BH-2 microscope (Olympus, Tokyo, Japan) linked
to a Macintosh Quadra-800 computer (Apple Computer, Cupertino, CA).
Microdensitometric measurements of OD were carried out after
calibration of the image gray scale level to the OD of a linear-step
neutral density filter and correcting for uneven illumination of the
camera field (3, 27).
Histochemical Techniques
Qualitative hATPase. For fiber typing, we used the techniques described by Brooke and Kaiser (5) and Guth and Samaha (19) as modified and carried out in our laboratory's previous work (7, 18, 27). Modifications to optimize the staining conditions for human skeletal muscles were made as follows. Briefly, we preincubated unfixed 10-µm sections for 7 min in a solution containing (in mM) 250 sodium acetate, 150 barbital sodium, and 100 HCl (pH 4.60). The sections were then rinsed for 1 min in a solution containing 18 mM CaCl2 and 100 mM Tris (pH 7.8). After they were rinsed, sections were incubated in a reaction mixture containing 0.01 mM ATP (disodium salt) and 100 mM 2-amino-2-methyl-1-propanol (Sigma no. 221 buffer) (pH 9.4) for 45 min at 25°C. These sections then underwent the following sequential treatments: 1) two 4.5-min washes with 1% CaCl2 (wt/vol); 2) placement in 2% CaCl2 (wt/vol) for 3 min; 3) a quick rinse in distilled water; 4) two 1-min washes with 10 mM barbital sodium; 5) a 30-s rinse in distilled water; 6) placement in 1% ammonium sulfide for 45 s; 7) rinse for 4 min in running water; and 8) air drying and mounting in glycerin gelatin (pH 7.2).
Individual fibers were analyzed by microdensitometric determination of OD, which reflects the degree of pH inhibition of the myosin ATPase in different types of fibers. It is well established that this histochemically determined OD directly correlates with MHC composition (11, 49). Under our experimental conditions, we noted three fiber types (i.e., I, IIa, and IIax). The OD ranges for these fiber types were established as fully described in a previous publication (7), i.e., OD of type I, >0.97; IIa, 0.20-0.40; and IIax, 0.41-0.80. In closing this section, we note that the IIb MHC isoform is not expressed in human skeletal muscle (11, 48). Therefore, our finding that the human diaphragm contains only I, IIa, and IIax fibers is consistent with our laboratory's prior observations (6-8, 18, 27) as well as those of others (11, 20) on human limb muscles.Quantitative histochemical determination of SDH activity. The method of Blanco et al. (3) was used for measurements of SDH in individual fibers that had been typed by the hATPase technique, as previously described (7, 18, 27). The histochemical assays were carried out within the linear range of the reaction product formation and in complete darkness. Briefly, 10-µm sections were incubated in a reaction mixture containing 9.3 mM succinate and 5 mM EDTA in buffer A [i.e., 20 µM 1-methoxy-5-methylphenazine methyl sulfate, 1.2 mM nitro blue tetrazolium (NBT), 10 µM sodium azide, and 100 mM phosphate buffer, pH 7.6] for 10 min in the dark at 25°C.
In these assays, substrate (i.e., succinate) was oxidized by 1-methoxy-5-methylphenazine methyl sulfate, which in turn was oxidized by NBT; this latter oxidation caused reduction of NBT to nitro blue diformazan (NBT-dfz), and this end product was measured at 570 nm. For each histochemically typed fiber, corrected OD values were obtained from the difference in OD between samples incubated in the presence of substrate and samples incubated in the absence of substrate. Fiber type-specific enzyme activity (expressed as micromoles of fumarate produced per liter tissue per minute) was then calculated according to the Lambert-Beer equation: [NBT-dfz] = OD/kl, where OD is the measured OD, k is the molar extinction coefficient of diformazan (26,478 M
1 · cm
1),
and l is the section thickness (10 µm).
Quantitative biochemical determination of calcium-activated
mATPase activity.
The method of Blanco and Sieck (4) was used for
determination of mATPase in single fibers as previously described
(6, 8, 18). Briefly, we incubated 6-µm serial sections
in six solutions of different ATP concentrations (0, 0.5, 1, 2, 3, 4, and 5 mM). For each of the above-noted ATP concentrations, the incubations were carried out for 4 min at 25°C in a solution having the following composition: 65 mM calcium chloride (dihydrate), 16 mg/ml
lead ammonium citrate-acetate complex, and 5 mM sodium azide prepared
in 50 mM Tris-maleate buffer, pH 7.6 (4, 20). The use of
incubations of different concentrations was necessary because, in
contrast to the assays for SDH activity, each of the mATPase reactions
was substrate limited. In this reaction, Pi is liberated by
the ATPase and reacts with a lead ammonium citrate-acetate complex to
form a lead-phosphate precipitate. This precipitate is converted to
lead sulfide by reaction with sodium sulfide, and the change in OD per
minute was measured at 570 nm. Subsequently, enzyme activity (expressed
as mmol
Pi · l
1 · min
1)
was determined by use of the Lambert-Beer equation with a molar extinction coefficient for lead sulfide of 1,450 M
1 · cm
1. We then used the
Michaelis-Menten model of enzyme kinetics to analyze the data, and the
reciprocal of the y-intercept of the Lineweaver-Burk plot
was taken as the maximum velocity of the mATPase.
Statistical Analysis
Data are presented as means ± SE. For all comparisons, we initially used a repeated-measures ANOVA (39) to control the rate of false positives at P < 0.05. However, once we noted a statistically significant group-by-fiber type interaction or main (i.e., group) effect, we utilized group t-tests for comparisons among groups and fiber types. For these latter two comparisons, we provide the nominal P values to serve as a measure of the statistical significance of differences noted between groups and fiber types. Additionally, when we compared ratios (e.g., SDH/mATPase), we used a natural logarithmic transformation to normalize the variance among groups and fiber types (53).| |
RESULTS |
|---|
|
|
|---|
Vital Statistics and Pulmonary Function Measurements
The COPD subjects did not differ significantly from the control subjects with respect to age, height, or weight (Table 1). The COPD subjects had greater residual volume, FRC, and total lung capacity than the control subjects, whereas the control subjects had higher values with respect to the FEV1, forced vital capacity, and the ratio of the FEV1 to forced vital capacity.
|
Fiber Type Proportions and Cross-Sectional Areas
Figure 1, A and B, compares control and COPD diaphragms with respect to the proportion of fiber types. In these sections, type I fibers stain dark, type IIa fibers stain light, and type IIax fibers stain intermediate between types I and IIa. A comparison of Fig. 1A and 1B indicates that the COPD diaphragms contain a greater proportion of type I fibers and a lesser proportion of type IIax fibers.
|
Figure 2A indicates that
control diaphragms contained the following proportions of types I, IIa,
and IIax, respectively: 42 ± 2, 27 ± 3, and 31 ± 5%.
In contrast, the figure indicates that COPD diaphragms contained the
following proportions of types I, IIa, and IIax, respectively: 71 ± 5, 21 ± 3, and 8 ± 3%. These data indicate that COPD
diaphragms exhibited a 29% increase (P = 0.0007) in
the proportion of type I fibers and a 23% decrease (P = 0.0026) in the proportion of type IIax fibers; no statistically significant difference was noted between COPD and control diaphragms with respect to the proportion of type IIa fibers.
|
Figure 2B indicates that type I fibers in the COPD diaphragms had a 41% smaller CSA (P = 0.0009) than those in control diaphragms. No statistically significant differences were noted between COPD and control diaphragms with respect to the CSA of type IIa or IIax fibers.
To examine the combined effect of changes in fiber type proportions and CSA, we calculated the relative contribution of each fiber type to the CSA of the diaphragm (i.e., area fraction or %CSA) as previously described (7, 18, 27, 52). (Because both COPD and control tissue sections had the same thickness, these area fractions also represent volume fractions.) The area fraction of type I fibers was increased (48 ± 4 vs. 73 ± 4%, P = 0.001) in COPD diaphragms, whereas the area fraction of type IIax fibers was decreased (28 ± 6 vs. 6 ± 2%, P = 0.01). COPD elicited no change in the area fraction of type IIa fibers.
SDH Activity
Figure 1, C and D, compares control and COPD diaphragms with respect to SDH activity. In these sections, the darkness of the fibers is directly related to SDH activity. Because these sections are serial to those shown in Fig. 1, A and B, the different fiber types can be compared with respect to SDH activity. A comparison of Fig. 1, C and D, suggests that all fiber types in the COPD diaphragms have a greater SDH activity than those in the control diaphragms.Figure 2C indicates that COPD elicited a group effect whereby all COPD fiber types had higher (P < 0.0001) SDH activity than the corresponding fiber type in control diaphragms. In COPD diaphragms, SDH activity of fiber types I, IIa, and IIax was increased above control by 84, 114, and 130%, respectively.
mATPase Activity
Figure 2D indicates that mATPase activity of all fiber types in the COPD diaphragms tended to be lower than those noted in control diaphragms; however, this decrease was statistically significant (P = 0.02) only in type IIax fibers.SDH-to-mATPase Ratio
As noted under Statistical Analysis, we used a logarithmic transformation of these ratios for our statistical comparisons, and Fig. 3 shows a plot of these log transformations. Our repeated-measures ANOVA showed a group-by-fiber type interaction; therefore, we used group t-tests to compare COPD and controls with respect to each of the fiber types. The figure shows that, for each of the fiber types, COPD diaphragms had a greater SDH/mATPase than the control diaphragms.
|
Additionally, we carried out repeated ANOVA on the nontransformed SDH/mATPase ratios. These analyses indicated that COPD elicited a group effect whereby all COPD fibers had higher (P = 0.03) SDH-to-mATPase ratios than the corresponding fiber type in control diaphragms. The SDH-to-mATPase ratios of COPD fibers expressed as percentage of control in types I, IIa, and IIax were 249, 295, and 357%, respectively.
Average Diaphragmatic Values for SDH, mATPase, and SDH/mATPase
In attempting to correlate enzyme activity of muscle strips containing multiple fiber types with FR, previous authors have utilized fiber type-specific measurements of enzyme activity, fiber type proportions, and fiber type areas to calculate the enzyme activity of a single fiber representation (i.e., a one-myofiber model) of the diaphragm (7, 18, 27, 52). When this is done with our data, Fig. 4A indicates that the representative COPD myofiber exhibited a twofold increase (P = 0.0002) in SDH activity over that of the control myofiber. Figure 4B shows that the COPD myofiber had a lower (P = 0.016) mATPase activity than the control myofiber. Last, Fig. 4C indicates that the representative COPD myofiber had a higher SDH/mATPase than the representative control myofiber.
|
| |
DISCUSSION |
|---|
|
|
|---|
Summary of New Findings
The new findings of the present study, when viewed from a fiber type-specific perspective, are that COPD elicited 1) a twofold increase in SDH activity in all fiber types, 2) a decrease in mATPase activity that was limited to type IIax fibers, and 3) an increase in SDH-to-mATPase activity ratios in all fiber types. When viewed from the perspective of the whole diaphragm, we noted 1) an increase in the area fraction of type I fibers, 2) a decrease in the area fraction of type IIax fibers, and 3) no change in the area fraction of type IIa fibers. Last, when viewed from the perspective of a single-myofiber representation of the diaphragm, SDH activity increased, mATPase activity decreased, and the SDH-to-mATPase activity ratio increased in COPD.Critique of Methodology
First, we recognize that an inherent limitation in our histochemical methodology is that it does not provide quantitative information about the relative proportions of the two MHC isoforms (i.e., IIa and IIx) in type IIax fibers. Second, some comment is warranted regarding the relationship between the decreases in CSA and the increases in SDH activity that was noted in all fiber types. Our methodology for evaluating SDH activity provides an average SDH activity for each fiber. Therefore, an increase in SDH can be effected by either an increase in SDH activity of the fiber or a decrease in fiber CSA. Figure 2B indicates that the COPD-associated decreases in fiber CSA for types I, IIa, and IIax fibers were 42, 21, and 21%, respectively; in contrast, the increases in SDH activity for types I, IIa, and IIax fibers were 84, 115, and 130%, respectively. On the basis of these data, we cannot exclude the possibility that the decreases in CSA contributed to the measured increases in SDH activity. However, these data indicate that the decrease in CSA cannot account for major portions of the increase in SDH activity noted in all fiber types.Interpretation of Results
SDH activity. First, we comment on our observations that, in each of the fiber types, COPD fibers had a higher SDH activity than control fibers. We interpret this finding as indicating that severe COPD elicits an increased capacity to generate ATP through aerobic oxidative pathways in each of the fiber types in the human diaphragm.
mATPase activity. We noted that, for all fiber types, mATPase activity was less in COPD fibers than in control fibers, although this difference was only statistically significant for the IIax fibers. The precise mechanism underlying these adaptations is not known. However, we hypothesize that, for each of the diaphragmatic fiber types, COPD fibers have a lower MHC concentration than control fibers, and this decrease in MHC concentration accounts for the decrease in mATPase activity.
Our notion regarding differences in MHC concentration among fibers can be viewed as a conceptual outgrowth of recent work by Geiger et al. (17) indicating that MHC content per half sarcomere of the rat diaphragm varies with fiber type in the following manner: fibers expressing IIb and/or IIx MHC(s) have a higher concentration of MHC per half sarcomere than fibers expressing slow or IIa MHCs. Han et al. (20) have demonstrated the applicability of these findings to the human vastus lateralis. Therefore, within the framework established by these workers, our hypothesis merely states that the presence or absence of severe COPD as well as fiber type are determinants of the MHC content and concentration in any given fiber.SDH/mATPase activity ratio. The relationship between fatigability and the SDH/mATPase warrants discussion. In the introduction, we noted that the work of Van der Laarse et al. (51) on single fibers from the lumbrical muscles of Xenopus laevis (a species of amphibian) and work of Watchko and Sieck (52) on the neonatal rat diaphragm indicate that a high degree of correlation was noted between the SDH/mATPase activity and FR. This concept is an intuitively attractive idea because it relates the FR of muscle to a balance between the quantitatively most important ATP-producing and -consuming reactions. However, neither of these papers provides a mechanistic interpretation of the manner in which an increase in SDH/mATPase increases FR. Therefore, we view the SDH/mATPase activity as being merely a biochemical indicator of FR at the myofiber level. Accordingly, we interpret the higher SDH/mATPase in our COPD diaphragms as suggesting that strips of COPD diaphragms would have a higher FR than those of control diaphragms.
Comparison of Our Human Work With That of Others
Observations on diaphragmatic adaptations elicited by COPD in humans. The literature contains a paucity of data on diaphragmatic adaptations of metabolic enzymes and fiber types associated with COPD. However, Sanchez and colleagues (45-47) in a series of papers showed that mild-to-moderate COPD [mean FEV1 60-70% of predicted normal (1)] elicited changes in neither mitochondrial oxidative enzyme activity nor fiber type proportions. Our unpublished observations also suggest that mild-to-moderate COPD does not elicit adaptations in either oxidative enzyme activities or fiber type proportions. However, Sanchez et al. (45, 47) reported that mild-to-moderate COPD elicited a decrease in CSA of both types I and II fibers. Additionally, Sanchez et al. (47) showed that decreases in their measure of CSA (i.e., least mean diameter) was positively correlated with the percent decrease in predicted body weight. Because Lewis et al. (35) and others (25) have demonstrated that nutritional depletion elicits decreases in CSA of both type I and type II fibers, the possibility exists that the decreases in CSA noted by Sanchez et al. were due to weight loss and not to some aspect of COPD per se.
Orozco-Levi et al. (42) recently reported that severe COPD elicits an increase in volume density of mitochondria in the diaphragm; this latter observation provides direct evidence for our supposition that the increases in SDH activity noted in our COPD diaphragms reflects an increase in the volume density of mitochondria. Last, in a rigorous study using both SDS-PAGE and native gels, Mercadier et al. (38) reported that patients with severe COPD exhibited a 56% increase in MHC I and a 44% decrease in type II MHCs. Their study did not measure any oxidative enzyme activities; however, their MHC data fully support our concept that severe COPD elicits fast-to-slow transformations in diaphragmatic MHCs and fiber types.Diaphragmatic Adaptations Elicited by Animal Models of COPD
Elastase-induced emphysema. Most work on experimental models of emphysema have utilized the response of the hamster diaphragm to elastase-induced emphysema (EIE). Using this model, Farkas and Roussos (14) demonstrated that EIE elicited a 20% increase in hamster diaphragmatic mitochondrial oxidative enzyme activity as assessed by biochemical determinations of citrate synthase. In subsequent work, Lewis et al. (34, 35) utilized quantitative histochemical techniques to demonstrate that EIE elicited a 28% increase in SDH activity of hamster diaphragmatic type I fibers whereas that of type II fibers increased 37%. At the present time, there appears to be general agreement that EIE in the hamster elicits increases in mitochondrial oxidative enzymes in all diaphragmatic fiber types, but the magnitudes of these increases are appreciably less than those noted in the diaphragms of patients with severe COPD. More importantly, both Farkas and Roussos (12) and Lewis et al. (34, 35) have demonstrated that EIE-induced increases in diaphragmatic mitochondrial oxidative activity are accompanied by increases in FR of muscle strips from these hamster diaphragms.
Two important differences exist between the adaptations of the hamster diaphragm to EIE and the human diaphragm to severe COPD. In the hamster diaphragm, the increases in oxidative enzyme activity are accompanied by an increase in CSA of both type I and II diaphragmatic fibers (23), whereas in the diaphragms of patients with severe COPD, the increases in oxidative activity are accompanied by a decrease in CSA of type I fibers and no statistically significant changes in CSA of IIa or IIax fibers. Moreover, the above-noted papers (14, 23, 34, 35) indicate that the hamster diaphragm adapts to EIE without any change in the relative proportions of types I and II fibers. In contrast, the present study as well as our laboratory's previous work (32, 33, 40) indicate that the diaphragms of patients with severe COPD exhibit an increase in the proportion of type I fibers and a decrease in the proportion of total type II fibers.Relationship of Diaphragm Adaptations Noted in COPD to Endurance Training
Patients with severe COPD manifest an increasing diaphragmatic resting energy expenditure, as evaluated by the diaphragm time-tension-index, both at rest (2) and during exercise (31). Moreover, recent work by De Troyer et al. (10) indicates that neural drive to the diaphragm of patients with severe COPD is markedly increased at rest. Therefore, we have hypothesized that that the diaphragms of patients with severe COPD can be conceptualized as undergoing at least moderate continuous endurance-type exercise. Accordingly, we have suggested that the adaptations elicited by severe COPD in the diaphragm are related to this state of continuous endurance type of exercise.Endurance exercise training of human limb muscles is usually associated with moderate increases in SDH activity as well as decreases in fiber CSA (9, 15, 16, 21, 37, 43); however, it is not associated with twofold increases in SDH activity and the fast-to-slow fiber type transformations that we observed in COPD diaphragms. Indeed, if the adaptations noted in the diaphragms of patients with severe COPD are related to this continuous increase in diaphragmatic energy expenditure (i.e., activity), this phenomenon would be unique for exercise-induced adaptations in mammalian skeletal muscle. However, some fundamental differences exist between the "diaphragm training" in severe COPD and limb muscle training protocols. Because the diaphragm is the only noncardiac striated muscle in humans that is continuously active, it carries out its training for 24 h/day, whereas limb muscle training protocols are limited to several hours per day. A second unique characteristic of the increased diaphragm work rate in severe COPD is that it probably occurs for at least several decades. Some exercise physiologists have suggested that endurance training may have the ability to elicit this fast-to-slow fiber type transformation, but "so far no lengthy human training study has unambiguously demonstrated such a shift" (1a). In closing, we respectfully suggest that the MHC and fiber type adaptations noted in our COPD diaphragms may represent an example of fast-to-slow fiber type transformations elicited by continuous long-term endurance training (i.e., several decades).
| |
ACKNOWLEDGEMENTS |
|---|
We thank Professor Greg Maislin for statistical advice and for assistance in carrying out the statistical analyses included in our manuscript.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: S. Levine, Medical Service, VA Medical Center, University and Woodland Aves., Philadelphia, PA 19004 (E-mail: sdlevine{at}mail.med.upenn.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00116.2001
Received 5 February 2001; accepted in final form 13 November 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
American Thoracic Society.
Lung function testing: selection of reference values and interpretative strategies.
Am Rev Respir Dis
144:
1202-1218,
1991[Web of Science][Medline].
1a.
Andersen, JL,
Schjerling P,
and
Saltin B.
Muscle, genes and athletic performance.
Sci Am
283:
48-55,
2000[Web of Science][Medline].
2.
Bellemare, F,
and
Grassino A.
Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease.
J Appl Physiol
55:
8-15,
1983
3.
Blanco, CE,
Sieck GC,
and
Edgerton VR.
Quantitative histochemical determination of succinic dehydrogenase activity in skeletal muscle fibres.
Histochem J
20:
230-243,
1988[Web of Science][Medline].
4.
Blanco, CE,
and
Sieck GC.
Quantitative determination of calcium-activated myosin adenosine triphosphatase activity in rat skeletal muscle fibres.
Histochem J
24:
431-444,
1992[Web of Science][Medline].
5.
Brooke, MH,
and
Kaiser KK.
Three myosin adenosine triphosphatase systems: the nature of their pH lability and sulfhydryl dependence.
J Histochem Cytochem
18:
670-672,
1970[Web of Science][Medline].
6.
Castro, MJ,
Kent-Braun JA,
Ng AV,
Miller RG,
and
Dudley GA.
Muscle fiber type-specific myofibrillar actomyosin Ca2+ ATPase activity in multiple sclerosis.
Muscle Nerve
21:
547-549,
1998[Web of Science][Medline].
7.
Castro, MJ,
Apple DF, Jr,
Staron RS,
Campos GE,
and
Dudley GA.
Influence of complete spinal cord injury on skeletal muscle within 6 mo of injury.
J Appl Physiol
86:
350-358,
1999
8.
Castro, MJ,
Apple DF, Jr,
Melton-Rogers S,
and
Dudley GA.
Muscle fiber type-specific myofibrillar Ca2+ ATPase activity after spinal cord injury.
Muscle Nerve
23:
119-121,
2000[Web of Science][Medline].
9.
Chilibeck, PD,
Bell GJ,
Socha T,
and
Martin T.
The effect of aerobic exercise training on the distribution of succinate dehydrogenase activity throughout muscle fibres.
Can J Appl Physiol
23:
74-86,
1998[Web of Science][Medline].
10.
De Troyer, A,
Leeper JB,
McKenzie DK,
and
Gandevia SC.
Neural drive to the diaphragm in patients with severe COPD.
Am J Respir Crit Care Med
155:
1335-1340,
1997[Abstract].
11.
Ennion, S,
Sant'ana Pereira J,
Sargeant AJ,
Young A,
and
Goldspink G.
Characterization of human skeletal muscle fibres according to the myosin heavy chains they express.
J Muscle Res Cell Motil
16:
35-43,
1995[Web of Science][Medline].
12.
Farkas, GA,
and
Roussos C.
Adaptability of the hamster diaphragm to exercise and/or emphysema.
J Appl Physiol
53:
1263-1272,
1982
13.
Farkas, GA,
and
Roussos C.
Diaphragm in emphysematous hamsters: sarcomere adaptability.
J Appl Physiol
54:
1635-1640,
1983
14.
Farkas, GA,
and
Roussos C.
Histochemical and biochemical correlates of ventilatory muscle fatigue in emphysematous hamsters.
J Clin Invest
74:
1214-1220,
1984.
15.
Fitts, R,
and
Widrick JJ.
Muscle mechanics: adaptations with exercise-training.
Exerc Sport Sci Rev
24:
427-473,
1996[Medline].
16.
Green, HJ,
Jones S,
Ball-Burnett M,
Farrance B,
and
Ranney D.
Adaptations in muscle metabolism to prolonged voluntary exercise and training.
J Appl Physiol
78:
138-145,
1995
17.
Geiger, PC,
Cody MJ,
Macken RL,
and
Sieck GC.
Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers.
J Appl Physiol
89:
695-703,
2000
18.
Gregory, CM,
Vandenborne K,
and
Dudley GA.
Metabolic enzymes and phenotypic expression among human locomotor muscles.
Muscle Nerve
24:
387-393,
2001[Web of Science][Medline].
19.
Guth, L,
and
Samaha FJ.
Qualitative differences between actomyosin ATPase of slow and fast mammalian muscle.
Exp Neurol
25:
138-152,
1969[Web of Science][Medline].
20.
Han, YS,
Proctor DN,
Geiger PC,
and
Sieck GC.
Reserve capacity for ATP consumption during isometric contraction in human skeletal muscle fibers.
J Appl Physiol
90:
657-664,
2001
21.
Jackson, CG,
Dickinson AL,
and
Ringel SP.
Skeletal muscle fiber area alterations in two opposing modes of resistance-exercise training in the same individual.
Eur J Appl Physiol
61:
37-41,
1990.
22.
Kanner, RE,
Morris AH,
Crapo RO,
and
Gardner RM.
Clinical Pulmonary Function Testing: a Manual of Uniform Laboratory Procedures for the Intermountain Area. Salt Lake City, UT: ITS, 1984.
23.
Kelsen, SG,
Wolanski T,
Supinski GS,
and
Roessmann U.
The effect of elastase-induced emphysema on diaphragmatic muscle structure in hamsters.
Am Rev Respir Dis
127:
330-334,
1983[Web of Science][Medline].
24.
Kelsen, SG,
Supinski GS,
and
Oliven A.
Diaphragm structure and function in elastase-induced emphysema.
Chest
85:
55S-58S,
1984
25.
Kelsen, SG,
Ference M,
and
Kapoor S.
Effects of prolonged undernutrition on structure and function of the diaphragm.
J Appl Physiol
58:
1354-1359,
1985
26.
Kelsen, SG,
Sexauer WP,
Mardini IA,
and
Criner GJ.
The comparative effects of elastase-induced emphysema on costal and crural diaphragm and parasternal intercostal muscle contractility.
Am J Respir Crit Care Med
149:
168-173,
1994[Abstract].
27.
Kent-Braun, JA,
Ng AV,
Castro M,
Weiner MW,
Gelinas D,
Dudley GA,
and
Miller RG.
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis.
J Appl Physiol
83:
1998-2004,
1997
28.
Knudson, RJ,
Lebowitz MD,
Holberg CJ,
and
Burrows B.
Changes in the normal maximal expiratory flow-volume curve with growth and aging.
Am Rev Respir Dis
127:
725-734,
1983[Web of Science][Medline].
29.
Larsson, L,
and
Skogsberg C.
Effects of the interval between removal and freezing of muscle biopsies on muscle fibre size.
J Neurol Sci
85:
27-38,
1988[Web of Science][Medline].
30.
Larsson, L,
Skogsberg C,
and
Gur H.
Influence of the interval between removal and freezing of muscle samples on muscle fibre size with special reference to sample size and fibre type.
Acta Physiol Scand
139:
451-458,
1990[Web of Science][Medline].
31.
Levine, S,
Gillen M,
Weiser P,
Feiss G,
Goldman M,
and
Henson D.
Inspiratory pressure generation: comparison of subjects with COPD and age-matched normals.
J Appl Physiol
65:
888-899,
1988
32.
Levine, S,
Kaiser L,
Leferovich J,
and
Tikunov B.
Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease.
N Engl J Med
337:
1799-1806,
1997
33.
Levine, S,
Nguyen T,
Shrager J,
Kaiser L,
Camasamudram V,
and
Rubinstein N.
Diaphragm adaptations elicited by severe chronic obstructive pulmonary disease: lessons for sports science.
Exerc Sport Sci Rev
29:
71-75,
2001[Medline].
34.
Lewis, MI,
Zhan WZ,
and
Sieck GC.
Adaptations of the diaphragm in emphysema.
J Appl Physiol
72:
934-943,
1992
35.
Lewis, MI,
Monn SA,
Zhan WZ,
and
Sieck GC.
Interactive effects of emphysema and malnutrition on diaphragm structure and function.
J Appl Physiol
77:
947-955,
1994
37.
Maltais, F,
LeBlanc P,
Simard C,
Jobin J,
Berube C,
Bruneau J,
Carrier L,
and
Belleau R.
Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med
154:
442-447,
1996[Abstract].
38.
Mercadier, JJ,
Schwartz K,
Schiaffino S,
Wisnewsky C,
Ausoni S,
Heimburger M,
Marrash R,
Pariente R,
and
Aubier M.
Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation.
Am J Physiol Lung Cell Mol Physiol
274:
L527-L534,
1998
39.
Morrison, DF.
Multivariate Statistical Methods. New York: McGraw-Hill, 1976.
40.
Nguyen, T,
Shrager J,
Kaiser L,
Mei L,
Daood M,
Watchko J,
Rubinstein N,
and
Levine S.
Developmental myosin heavy chains in the adult human diaphragm: coexpression patterns and effect of COPD.
J Appl Physiol
88:
1446-1456,
2000
41.
NHLBI workshop summary.
Respiratory muscle fatigue. Report of the Respiratory Muscle Fatigue Workshop Group.
Am Rev Respir Dis
142:
474-480,
1990[Web of Science][Medline].
42.
Orozco-Levi, M,
Gea J,
Lloreta JL,
Felez M,
Minguella J,
Serrano S,
and
Broquetas JM.
Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease.
Eur Respir J
13:
371-378,
1999[Abstract].
43.
Proctor, DN,
Sinning WE,
Walro JM,
Sieck GC,
and
Lemon PW.
Oxidative capacity of human muscle fiber types: effects of age and training status.
J Appl Physiol
78:
2033-2038,
1995
44.
Roussos, CS,
and
Macklem PT.
Diaphragmatic fatigue in man.
J Appl Physiol
43:
189-197,
1977
45.
Sanchez, J,
Derenne JP,
Debesse B,
Riquet M,
and
Monod H.
Typology of the respiratory muscles in normal men and in patients with moderate chronic respiratory diseases.
Bull Eur Physiopath Respir
18:
901-914,
1982[Web of Science][Medline].
46.
Sanchez, J,
Bastien C,
Medrano G,
Riquet M,
and
Derenne JP.
Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease.
Bull Eur Physiopath Respir
20:
535-540,
1984[Web of Science][Medline].
47.
Sanchez, J,
Medrano G,
Debesse B,
Riquet M,
and
Derenne JP.
Muscle fibre types in costal and crural diaphragm in normal men and in patients with moderate chronic respiratory disease.
Bull Eur Physiopath Respir
21:
351-356,
1985[Web of Science][Medline].
48.
Smerdu, V,
Karsch-Mizrachi I,
Campione M,
Leinwand L,
and
Schiaffino S.
Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle.
Am J Physiol Cell Physiol
267:
C1723-C1728,
1994
49.
Staron, RS.
Correlation between myofibrillar ATPase activity and myosin heavy chain composition in single human muscle fibers.
Histochemistry
96:
21-24,
1991[Web of Science][Medline].
50.
Supinski, GS,
and
Kelsen SG.
Effect of elastase-induced emphysema on the force-generating ability of the diaphragm.
J Clin Invest
70:
978-988,
1982.
51.
Van der Laarse, WJ,
Lannergren J,
and
Diegenbach PC.
Resistance to fatigue of single muscle fibres from Xenopus related to succinate dehydrogenase and myofibrillar ATPase activities.
Exp Physiol
76:
589-596,
1991[Abstract].
52.
Watchko, JF,
and
Sieck GC.
Respiratory muscle fatigue resistance relates to myosin phenotype and SDH activity during development.
J Appl Physiol
75:
1341-1347,
1993
53.
Winer, BJ.
Statistical Principles in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971, p. 397-402.
This article has been cited by other articles:
![]() |
M.-A. Caron, R. Debigare, P. N. R. Dekhuijzen, and F. Maltais Comparative assessment of the quadriceps and the diaphragm in patients with COPD J Appl Physiol, September 1, 2009; 107(3): 952 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. McKenzie, J. E. Butler, and S. C. Gandevia Respiratory muscle function and activation in chronic obstructive pulmonary disease J Appl Physiol, August 1, 2009; 107(2): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Clanton and S. Levine Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Appl Physiol, July 1, 2009; 107(1): 324 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marin-Corral, J. Minguella, A. L. Ramirez-Sarmiento, S. N. A. Hussain, J. Gea, and E. Barreiro Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients Eur. Respir. J., June 1, 2009; 33(6): 1309 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Stubbings, A. J. Moore, M. Dusmet, P. Goldstraw, T. G. West, M. I. Polkey, and M. A. Ferenczi Physiological properties of human diaphragm muscle fibres and the effect of chronic obstructive pulmonary disease J. Physiol., May 15, 2008; 586(10): 2637 - 2650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McKenzie To breathe or not to breathe: the respiratory muscles and COPD J Appl Physiol, November 1, 2006; 101(5): 1279 - 1280. [Full Text] [PDF] |
||||
![]() |
S. Levine, T. Nguyen, M. Friscia, J. Zhu, W. Szeto, J. C. Kucharczuk, B. A. Tikunov, N. A. Rubinstein, L. R. Kaiser, and J. B. Shrager Parasternal intercostal muscle remodeling in severe chronic obstructive pulmonary disease J Appl Physiol, November 1, 2006; 101(5): 1297 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. C. Ottenheijm, L. M. A. Heunks, Y.-P. Li, B. Jin, R. Minnaard, H. W. H. van Hees, and P. N. R. Dekhuijzen Activation of the Ubiquitin-Proteasome Pathway in the Diaphragm in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2006; 174(9): 997 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jelic and T. H. Le Jemtel Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure. Chest, October 1, 2006; 130(4): 1220 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nici, C. Donner, E. Wouters, R. Zuwallack, N. Ambrosino, J. Bourbeau, M. Carone, B. Celli, M. Engelen, B. Fahy, et al. American thoracic society/european respiratory society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med., June 15, 2006; 173(12): 1390 - 1413. [Full Text] [PDF] |
||||
![]() |
C. A. C. Ottenheijm, L. M. A. Heunks, T. Hafmans, P. F. M. van der Ven, C. Benoist, H. Zhou, S. Labeit, H. L. Granzier, and P. N. R. Dekhuijzen Titin and Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 527 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Scott, X. Wang, J. D. Road, and W. D. Reid Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations Eur. Respir. J., January 1, 2006; 27(1): 51 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. C. Ottenheijm, L. M. A. Heunks, G. C. Sieck, W.-Z. Zhan, S. M. Jansen, H. Degens, T. de Boo, and P. N. R. Dekhuijzen Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 200 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF] |
||||
![]() |
T. Nguyen, N. A. Rubinstein, C. Vijayasarathy, L. C. Rome, L. R. Kaiser, J. B. Shrager, and S. Levine Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm J Appl Physiol, June 1, 2005; 98(6): 2004 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barreiro, B. de la Puente, J. Minguella, J. M. Corominas, S. Serrano, S. N. A. Hussain, and J. Gea Oxidative Stress and Respiratory Muscle Dysfunction in Severe Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1116 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 598 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doucet, R. Debigare, D.R. Joanisse, C. Cote, P. LeBlanc, J. Gregoire, J. Deslauriers, R. Vaillancourt, and F. Maltais Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD Eur. Respir. J., December 1, 2004; 24(6): 971 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morita, K. Iizuka, K. Okita, T. Oikawa, K. Yonezawa, T. Nagai, Y. Tokumitsu, T. Murakami, A. Kitabatake, and H. Kawaguchi Exposure to pressure stimulus enhances succinate dehydrogenase activity in L6 myoblasts Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1064 - E1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Polla, G D'Antona, R Bottinelli, and C Reggiani Respiratory muscle fibres: specialisation and plasticity Thorax, September 1, 2004; 59(9): 808 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D.-C. Man, J. Moxham, H. Montgomery, and M. I. Polkey Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 395 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. Mattson, M.D. Delp, and D.C. Poole Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Eur. Respir. J., May 1, 2004; 23(5): 703 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.I. Polkey and J. Moxham Improvement in volitional tests of muscle function alone may not be adequate evidence that inspiratory muscle training is effective Eur. Respir. J., January 1, 2004; 23(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
M. Orozco-Levi Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur. Respir. J., November 2, 2003; 22(46_suppl): 41s - 51s. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.T. Jagoe and M.P.K.J. Engelen Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 52s - 63s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levine, T. Nguyen, L. R. Kaiser, N. A. Rubinstein, G. Maislin, C. Gregory, L. C. Rome, G. A. Dudley, G. C. Sieck, and J. B. Shrager Human Diaphragm Remodeling Associated with Chronic Obstructive Pulmonary Disease: Clinical Implications Am. J. Respir. Crit. Care Med., September 15, 2003; 168(6): 706 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
W D-C Man, M G G Soliman, D Nikoletou, M L Harris, G F Rafferty, N Mustfa, M I Polkey, and J Moxham Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease Thorax, August 1, 2003; 58(8): 665 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ribera, B. N'Guessan, J. Zoll, D. Fortin, B. Serrurier, B. Mettauer, X. Bigard, R. Ventura-Clapier, and E. Lampert Mitochondrial Electron Transport Chain Function Is Enhanced in Inspiratory Muscles of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 873 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levine, T. Nguyen, L. R. Kaiser, and J. B. Shrager Evaluating Respiratory Muscle Adaptations: A New Approach Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1418 - 1419. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |